Jeffrey Harrison William, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nephrology | 3 | 2023 | 270 | 1.590 |
Why?
|
Magnesium Deficiency | 2 | 2018 | 48 | 1.100 |
Why?
|
Students, Medical | 3 | 2023 | 1962 | 0.980 |
Why?
|
Kidney Failure, Chronic | 4 | 2024 | 2505 | 0.960 |
Why?
|
Magnesium | 3 | 2018 | 815 | 0.910 |
Why?
|
Renal Dialysis | 3 | 2024 | 1790 | 0.800 |
Why?
|
Proton Pump Inhibitors | 3 | 2015 | 550 | 0.750 |
Why?
|
Renal Replacement Therapy | 1 | 2020 | 282 | 0.580 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2024 | 2306 | 0.570 |
Why?
|
Kwashiorkor | 1 | 2014 | 24 | 0.480 |
Why?
|
Antihypertensive Agents | 1 | 2024 | 2029 | 0.470 |
Why?
|
Diabetic Nephropathies | 1 | 2020 | 975 | 0.420 |
Why?
|
Curriculum | 2 | 2023 | 3783 | 0.400 |
Why?
|
Education, Medical | 1 | 2023 | 1744 | 0.380 |
Why?
|
Metabolic Diseases | 1 | 2018 | 686 | 0.380 |
Why?
|
Computer-Assisted Instruction | 1 | 2013 | 368 | 0.350 |
Why?
|
Practice Guidelines as Topic | 2 | 2024 | 7426 | 0.300 |
Why?
|
Homeostasis | 1 | 2018 | 3341 | 0.270 |
Why?
|
Gastric Bypass | 1 | 2014 | 820 | 0.260 |
Why?
|
Glaucoma | 1 | 2015 | 1194 | 0.250 |
Why?
|
Hemodialysis, Home | 1 | 2024 | 21 | 0.240 |
Why?
|
Hypertension | 2 | 2024 | 8614 | 0.240 |
Why?
|
Point-of-Care Systems | 1 | 2013 | 1217 | 0.240 |
Why?
|
Kidney | 2 | 2023 | 7071 | 0.240 |
Why?
|
Peritoneal Dialysis | 1 | 2024 | 161 | 0.220 |
Why?
|
Kidney Diseases | 1 | 2013 | 2101 | 0.200 |
Why?
|
Internal Medicine | 2 | 2024 | 1063 | 0.200 |
Why?
|
Diet, Sodium-Restricted | 1 | 2024 | 291 | 0.190 |
Why?
|
Calcimimetic Agents | 1 | 2021 | 12 | 0.190 |
Why?
|
Staff Development | 1 | 2023 | 231 | 0.180 |
Why?
|
Blood Pressure Determination | 1 | 2024 | 646 | 0.170 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2021 | 123 | 0.170 |
Why?
|
Faculty | 1 | 2023 | 383 | 0.170 |
Why?
|
Thinking | 1 | 2022 | 320 | 0.160 |
Why?
|
Potassium | 1 | 2023 | 1314 | 0.160 |
Why?
|
Parathyroidectomy | 1 | 2021 | 244 | 0.160 |
Why?
|
Drug Resistance | 1 | 2024 | 1591 | 0.150 |
Why?
|
Career Choice | 1 | 2022 | 768 | 0.120 |
Why?
|
Glomerular Filtration Rate | 1 | 2024 | 2230 | 0.120 |
Why?
|
Humans | 19 | 2024 | 766432 | 0.120 |
Why?
|
Pancreatic Function Tests | 1 | 2014 | 69 | 0.120 |
Why?
|
Intestinal Absorption | 1 | 2015 | 400 | 0.120 |
Why?
|
Malabsorption Syndromes | 1 | 2014 | 135 | 0.110 |
Why?
|
Disease Management | 1 | 2024 | 2530 | 0.110 |
Why?
|
Acid-Base Imbalance | 1 | 2013 | 41 | 0.110 |
Why?
|
Referral and Consultation | 2 | 2024 | 3616 | 0.110 |
Why?
|
Liver Function Tests | 1 | 2014 | 527 | 0.110 |
Why?
|
Medication Adherence | 1 | 2024 | 2189 | 0.100 |
Why?
|
Feasibility Studies | 1 | 2023 | 5302 | 0.100 |
Why?
|
Hyponatremia | 1 | 2013 | 278 | 0.090 |
Why?
|
Down-Regulation | 2 | 2014 | 2930 | 0.090 |
Why?
|
Pilot Projects | 1 | 2023 | 8720 | 0.080 |
Why?
|
Education, Medical, Graduate | 1 | 2022 | 2419 | 0.080 |
Why?
|
Intraocular Pressure | 1 | 2015 | 1304 | 0.080 |
Why?
|
Cataract | 1 | 2015 | 837 | 0.080 |
Why?
|
Activity Cycles | 1 | 2007 | 47 | 0.070 |
Why?
|
United States | 4 | 2024 | 72910 | 0.070 |
Why?
|
Hypoglycemic Agents | 1 | 2020 | 3107 | 0.070 |
Why?
|
Leisure Activities | 1 | 2007 | 310 | 0.060 |
Why?
|
Insulin | 1 | 2020 | 6608 | 0.060 |
Why?
|
Program Evaluation | 1 | 2013 | 2503 | 0.060 |
Why?
|
Boston | 2 | 2014 | 9333 | 0.060 |
Why?
|
Work Schedule Tolerance | 1 | 2007 | 553 | 0.050 |
Why?
|
Prevalence | 1 | 2020 | 15820 | 0.050 |
Why?
|
Social Environment | 1 | 2007 | 1012 | 0.050 |
Why?
|
Incidence | 1 | 2020 | 21509 | 0.050 |
Why?
|
Sleep Deprivation | 1 | 2007 | 848 | 0.040 |
Why?
|
Sodium, Dietary | 1 | 2024 | 426 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 8042 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2024 | 15639 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2021 | 15818 | 0.040 |
Why?
|
Focus Groups | 1 | 2024 | 1459 | 0.040 |
Why?
|
Female | 5 | 2021 | 396354 | 0.030 |
Why?
|
Internship and Residency | 1 | 2013 | 5944 | 0.030 |
Why?
|
Adult | 4 | 2014 | 223253 | 0.030 |
Why?
|
Histamine H2 Antagonists | 1 | 2013 | 167 | 0.020 |
Why?
|
Risk Factors | 2 | 2015 | 74828 | 0.020 |
Why?
|
Linear Models | 2 | 2013 | 5872 | 0.020 |
Why?
|
Polypharmacy | 1 | 2013 | 307 | 0.020 |
Why?
|
Diuretics | 1 | 2013 | 611 | 0.020 |
Why?
|
Phosphates | 1 | 2013 | 763 | 0.020 |
Why?
|
Middle Aged | 4 | 2021 | 223127 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2021 | 5337 | 0.020 |
Why?
|
Aged | 3 | 2014 | 171234 | 0.020 |
Why?
|
Patient Admission | 1 | 2013 | 1364 | 0.020 |
Why?
|
Animals | 1 | 2015 | 168887 | 0.010 |
Why?
|
Male | 3 | 2021 | 363975 | 0.010 |
Why?
|
Sex Distribution | 1 | 2007 | 2272 | 0.010 |
Why?
|
Age Distribution | 1 | 2007 | 2868 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12061 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2013 | 3798 | 0.010 |
Why?
|
Attitude to Health | 1 | 2007 | 2021 | 0.010 |
Why?
|
Logistic Models | 1 | 2013 | 13276 | 0.010 |
Why?
|
Comorbidity | 1 | 2013 | 10579 | 0.010 |
Why?
|
Health Status | 1 | 2007 | 4085 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 26294 | 0.010 |
Why?
|
Risk Assessment | 1 | 2013 | 24272 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2013 | 59538 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2013 | 65202 | 0.000 |
Why?
|
Adolescent | 1 | 2007 | 88898 | 0.000 |
Why?
|